IL-15 also manifested the risk of thrombocytopenia with an evident reduction in platelet and red blood cell counts, whereas biomimetic nanovaccine-mediated IL-15 self-transpresentation displayed no overt toxicity even under the maximum administrable dosage (Fig. 4g, h). The gene discussed is IL15; the disease is Thrombocytopenia.